Which of the following drugs is associated with untoward side effect of renal tubular damage-
**Core Concept**
Cisplatin is a platinum-based chemotherapy drug used to treat various types of cancers, including testicular, ovarian, lung, bladder, and stomach cancers. Its mechanism of action involves cross-linking DNA, thereby inhibiting cell division. However, one of the significant side effects of cisplatin is its nephrotoxicity, which can lead to renal tubular damage.
**Why the Correct Answer is Right**
Cisplatin causes renal tubular damage by inducing oxidative stress and inflammation in the renal tubules. This leads to the release of pro-inflammatory cytokines, activation of various signaling pathways, and ultimately, damage to the renal tubular cells. The mechanism of cisplatin-induced nephrotoxicity involves the generation of reactive oxygen species (ROS) and the depletion of glutathione levels in the renal tubules, making them more susceptible to damage.
**Why Each Wrong Option is Incorrect**
**Option A:** Steptozotocin is a drug used to induce diabetes in experimental animals, but it is not commonly associated with renal tubular damage. It works by inhibiting pancreatic beta-cell function, leading to hyperglycemia.
**Option B:** Methysergide is a serotonin receptor antagonist used to treat migraines and cluster headaches. It is not known to cause renal tubular damage and is primarily metabolized by the liver.
**Option D:** Cyclophosphamide is an alkylating agent used in chemotherapy, but it is more commonly associated with hemorrhagic cystitis due to its metabolite acrolein. While it can cause renal toxicity, it is not specifically known for causing renal tubular damage.
**Clinical Pearl / High-Yield Fact**
It's essential to remember that patients receiving cisplatin should be closely monitored for signs of nephrotoxicity, including decreased urine output, hyperkalemia, and elevated serum creatinine levels. Early detection and management of cisplatin-induced nephrotoxicity can help minimize its severity and improve patient outcomes.
β Correct Answer: A. Cisplatin